Conformational changes and cleavage; are these responsible for the tau aggregation in Alzheimer’’s disease?

Author： Mondragóón-Rodrííguez Siddhartha   Basurto-Islas Gustavo   Binder Lester I   Garcíía-Sierra Francisco  

Publisher： Future Medicine

ISSN： 1479-6708

Source： Future Neurology, Vol.4, Iss.1, 2009-01, pp. : 39-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tau Therapeutics for Alzheimer’s Disease : The Promise and the Challenges

By Gold Michael  

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 329-334

Humana Press, Inc

Access to resources Recommend Favorite

Tau as a Drug Target in Alzheimer’s Disease

By Gozes Illana  

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 337-338

Humana Press, Inc

Access to resources Recommend Favorite

TAU Aggregation is a Therapeutic Target for Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 7, Iss. 8, 2010-12 ,pp. : 665-669

Bentham Science Publishers

Access to resources Recommend Favorite

Tau Conformational Changes Correspond to Impairments of Episodic Memory in Mild Cognitive Impairment and Alzheimer's Disease

By Ghoshal N.   García-Sierra F.   Wuu J.   Leurgans S.   Bennett D.A.   Berry R.W.   Binder L.I.  

Experimental Neurology, Vol. 177, Iss. 2, 2002-10 ,pp. : 475-493

Academic Press

Access to resources Recommend Favorite

Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology

By Obulesu M.   Venu R.   Somashekhar R.  

Neurochemical Research, Vol. 36, Iss. 8, 2011-08 ,pp. : 1329-1335

Springer Publishing Company

Access to resources Recommend Favorite